The head of the US Food and Drug Administration’s division of vaccines and gene therapies is leaving the agency after a tumultuous tenure, sending biotech shares higher in late trading on Friday.
The Federal Circuit revived a patent dispute against Microsoft Corp.'s cloud platform Azure by reversing the tech giant’s summary judgment win while reversing a Texas federal judge’s decision to exclude opposing damages testimony.
Becton Dickinson & Co. and C.R. Bard Inc. largely lost their bid for summary judgment in a bellwether plaintiff’s suit alleging the companies’ implanted port catheters were defective and led to medical complications.
Ohio’s attorney general sued
For nearly three years, the two sides have battered each other with relentless legal filings in a New York court, and their war over who should pay at least hundreds of millions of dollars to sex abuse victims shows few signs of abating. Both accuse the other of an underhanded public relations campaign.
UniQure NV’s gene therapy for Huntington’s disease is a failed product, a senior US Food and Drug Administration official said Thursday, dimming the company’s hopes that it can persuade the agency to reconsider its demand for a rigorous new clinical trial.
Kinsale Insurance Co. has no duty to defend or indemnify Fresh Farms E-Liquid LLC for litigation brought by a consumer who alleged she suffered a psychotic breakdown after ingesting gummies the company manufactured and distributed.
The US is considering using the emergency powers of a Cold War-era law to ease permitting for
The EPA says more than 600 PFAS chemicals are in the marketplace in the U.S. While states are racing to regulate PFAS, while the federal government lags.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas:
